Dynamics of Influenza Virus Infection and Pathology
暂无分享,去创建一个
Ann Cullinane | Julia R. Gog | Bryan T. Grenfell | John W. McCauley | Roberto A. Saenz | J. Gog | B. Grenfell | J. Wood | J. Daly | J. Mumford | S. Macrae | P. Digard | J. McCauley | D. Elton | R. Saenz | M. Quinlivan | A. Cullinane | Paul Digard | James L. N. Wood | Michelle Quinlivan | Debra Elton | Shona MacRae | Anthony S. Blunden | Jennifer A. Mumford | Janet M. Daly | A. Blunden | J. Wood | J. Wood | Michelle Quinlivan
[1] Yi Guan,et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.
[2] J. Crapo,et al. Allometric relationships of cell numbers and size in the mammalian lung. , 1992, American journal of respiratory cell and molecular biology.
[3] R. Webster,et al. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses , 2002, Nature Medicine.
[4] T. Taniguchi,et al. Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-α/β Gene Induction , 2000 .
[5] C. Basler,et al. Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. , 2008, Antiviral research.
[6] Yi Guan,et al. Avian Influenza Virus (H5N1): a Threat to Human Health , 2007, Clinical Microbiology Reviews.
[7] Ann Cullinane,et al. Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus. , 2007, Vaccine.
[8] J. Mumford,et al. Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. , 1990, Equine veterinary journal.
[9] A. García-Sastre,et al. Attenuation of Equine Influenza Viruses through Truncations of the NS1 Protein , 2005, Journal of Virology.
[10] N. Dimmock,et al. Insights into neutralization of animal viruses gained from study of influenza virus , 1991, Epidemiology and Infection.
[11] B. G. Hale,et al. The multifunctional NS1 protein of influenza A viruses. , 2008, The Journal of general virology.
[12] C. Cockram,et al. A Man with Labile Blood Pressure , 2007, PLoS medicine.
[13] S. Goodbourn,et al. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. , 2008, The Journal of general virology.
[14] Andreas Handel,et al. Towards a quantitative understanding of the within-host dynamics of influenza A infections , 2010, Journal of The Royal Society Interface.
[15] Gavin J. D. Smith,et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic , 2009, Nature.
[16] R. Webby,et al. Mutations in the NS1 Protein of Swine Influenza Virus Impair Anti-Interferon Activity and Confer Attenuation in Pigs , 2005, Journal of Virology.
[17] M. Katze,et al. Global Host Immune Response: Pathogenesis and Transcriptional Profiling of Type A Influenza Viruses Expressing the Hemagglutinin and Neuraminidase Genes from the 1918 Pandemic Virus , 2004, Journal of Virology.
[18] A. McMichael,et al. The immunology of influenza. , 1985, British medical bulletin.
[19] S. Goodbourn,et al. NS1 Proteins of Avian Influenza A Viruses Can Act as Antagonists of the Human Alpha/Beta Interferon Response , 2006, Journal of Virology.
[20] J. Peiris,et al. Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.
[21] W. Doyle,et al. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. , 1999, The Journal of infectious diseases.
[22] Gilles Clermont,et al. A Dynamical Model of Human Immune Response to Influenza a Virus Infection , 2006 .
[23] P. Yates,et al. Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses. , 2003, Viral immunology.
[24] Roger E Bumgarner,et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Daly,et al. Investigation of equine influenza cases exhibiting neurological disease: coincidence or association? , 2006, Journal of comparative pathology.
[26] J. Taubenberger,et al. The pathology of influenza virus infections. , 2008, Annual review of pathology.
[27] I. Clark,et al. The advent of the cytokine storm , 2007, Immunology and cell biology.
[28] G. Kochs,et al. Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein , 2007, Journal of Virology.
[29] A. Perelson,et al. Kinetics of Influenza A Virus Infection in Humans , 2006, Journal of Virology.
[30] F. Dianzani,et al. Tissue culture models of in vivo interferon production and action. , 1978, Advances in experimental medicine and biology.
[31] A. Perelson,et al. Simulation and Prediction of the Adaptive Immune Response to Influenza A Virus Infection , 2009, Journal of Virology.
[32] K. Melén,et al. Inflammatory responses in influenza A virus infection. , 2000, Vaccine.
[33] Michelle M. Packard,et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] G. Ada,et al. The immune response to influenza infection. , 1986, Current topics in microbiology and immunology.
[35] J. Sedmak,et al. Interferon bioassay: reduction in yield of myxovirus neuraminidases. , 1973, The Journal of general virology.
[36] A. Fernández-Sesma. The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. , 2007, Infectious disorders drug targets.
[37] Andreas Handel,et al. Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread , 2007, PLoS Comput. Biol..
[38] Y. Guan,et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.
[39] A H Rowberg,et al. Influenza virus population dynamics in the respiratory tract of experimentally infected mice , 1976, Infection and immunity.
[40] M. Peruggia. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach (2nd ed.) , 2003 .
[41] John Samuel,et al. A simple cellular automaton model for influenza A viral infections. , 2004, Journal of theoretical biology.
[42] D. Levy,et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.
[43] Hidekazu Nishimura,et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus , 2004, Nature.
[44] J. Dai,et al. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. , 2008, Cytokine & growth factor reviews.
[45] A S Perelson,et al. Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.
[46] S. Goodbourn,et al. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. , 2006, Virology.
[47] B. Levin,et al. Antiviral Resistance and the Control of Pandemic Influenza , 2007, PLoS medicine.
[48] G. Bocharov,et al. Mathematical model of antiviral immune response. III. Influenza A virus infection. , 1994, Journal of theoretical biology.
[49] David R. Anderson,et al. Model selection and multimodel inference : a practical information-theoretic approach , 2003 .